Synaptojanin 2 recognized by HLA class II-restricted hairy cell leukemia-specific T cells

Leukemia

Volumn 17, Issue 12, 2003, Pages 2467-2473

  Spaenij Dekking, E H A ^a   Van Delft, J ^a   Vad der Meijden, E ^a   Hiemstra, H S ^a   Falkenburg, J H F ^a   Koning, J H F ^a   Drijfhout, J W ^a   Kluin Nelemans, J C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

CD4T cell epitope; Hairy cell leukemia; Peptide library; Synaptojanin 2

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 2; PEPTIDE LIBRARY; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; SYNAPTOJANIN; SYNAPTOJANIN 2; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CELL CLONE; CELL GROWTH; CONTROLLED STUDY; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; T CELL LEUKEMIA; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 0346656662     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403174     Document Type: Article

References (42)

1. Cawley JC, Burns GF, Hayhoe GJ. Hairy-cell leukaemia. Recent Results Cancer Res 1980; 72: 1-123.
2. Zucker-Franklin D, Liebes LF, Silber R. Differences in the behavior of the membrane and membrane-associated filamentous structures in normal and chronic lymphocytic leukemia (CLL) lymphocytes. J Immunol 1979; 122: 97-107.
3. Kluin-Nelemans IC, Kester MGD, Melenhorst JJ, Landegent JE, van de Corput L, Willemze R et al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996; 87: 3795-3802.
4. Stark RS, Liebes LF, Shelanski ML, Silber R. Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes. Blood 1984; 63: 415-420.
5. Caligaris-Cappio F, Bergui L, Tesio L, Corbascio G, Tousco F, Marchisio PC. Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia. Blood 1986; 67: 233-239.
6. Berger R, Bernheim A, Valensi F, Flandrin G. 14q- in two hairy cell leukemia patients. Cancer Genet Cytogenet 1985; 16: 91-93.
7. Lewis JP, Tanke HJ, Raap AK, Kibbelaar RE, Kluin PM, Kluin-Nelemans HC. Hairy cell leukemia: an interphase cytogenetic study. Leukemia 1993; 7: 1334-1338.
8. Haglund U, Juliusson G, Stellan B, Gahrton G. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 1994; 83: 2637-2645.
9. Kluin-Nelemans HC, Beverstock GC, Mollevanger P, Wessels HW, Hoogendoorn E, Willemze R et al. Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84: 3134-3141.
10. de Santi MM, Leoncini L, Del Vecchio MT. Tubuloreticular inclusions and viral particles in a case of hairy cell leukemia. Haematologica 1989; 74: 413-414.
11. Mantovani G, Santa CG, Serra MC. Tubuloreticular inclusions and viral particles in hairy cell leukemia. Haematologica 1990; 75: 403.
12. Kluin-Nelemans HC, Kester MGD, van de Corput L, Boor PPC, Landegent JE, van Dongen JJM et al. Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood 1998; 91: 4224-4231.
13. van der Horst FA, van der Marel A, den Ottolander GJ, Kluin-Nelemans HC. Decrease of memory T helper cells (CD4+ CD45R0+) in hairy cell leukemia. Leukemia 1993; 7: 46-50.
14. Van de Corput L, Kluin-Nelemans HC, Kester MGD, Willemze R, Falkenburg JHF. Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. Blood 1999; 93: 251-259.
15. Hiemstra HS, Benckhuijsen WE, Amons R, Rapp W, Drijfhout JW. A new hybrid resin for stepwise screening of peptide libraries combined with single bead Edman sequencing. J Pept Sci 1998; 4: 282-288.
16. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 1994; 39: 230-242.
17. Lam KS, Salmon SE, Hersh EM, Hruby VJ, Kazmierski WM et al. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 1991; 354: 82-84.
18. Lebl M, Krchnak V. Synthetic peptide libraries. Methods Enzymol 1997; 289: 336-392.
19. Hiemstra HS, Duinkerken G, Benckhuijsen WE, Amons R, de Vries RRP, Roep BO et al. The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci USA 1997; 94: 10313-10318.
20. Falkenburg JHF, Harrington MA, Walsh WK, Daub R, Broxmeyer HE. Gene-expression and release of macrophage-colony stimulating factor in quiescent and proliferating fibroblasts. Effects of serum, fibroblast growth-promoting factors, and IL-1. J Immunol 1990; 144: 4657-4662.
21. Malecz N, McCabe PC, Spaargaren C, Qiu R, Chuang Y, Symons M. Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis. Curr Biol 2000; 10: 1383-1386.
22. Heemskerk MH, de Paus RA, Lurvink EGA, Koning F, Mulder A, Willemze R et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci USA 2001; 98: 6806-6811.
23. Hiemstra HS, van Veelen PA, Schloot NC, Geluk A, van Meijgaarden KE, Willemen SJM et al. Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries. J Immunol 1998; 161: 4078-4082.
24. Heemskerk MH, Blom B, Nolan G, Stegmann APA, Bakker AQ, Weijer K et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med 1997; 186: 1597-1602.
25. Chiari R, Hames G, Stroobant V, Texier C, Maillere B, Boon T et al. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4T cells on HLA class II molecules. Cancer Res 2000; 60: 4855-4863.
26. Fujii S, Uemura Y, Iwai LK, Ando M, Senju S, Nishimura Y. Establishment of an expression cloning system for CD4+ T cell epitopes. Biochem Biophys Res Commun 2001; 284: 1140-1147.
27. Verreck FAW, Vermeulen C, Poel van A, Jorritsma P, Amons R, Coligan JE et al. The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding. Int Immunol 1996; 8: 397-404.
28. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Papadopoulos GK, Koning F. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule. Immunogenetics; 1997; 46: 484-492.
29. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule. Immunogenetics 1996; 44: 246-253.
30. Gundlach BR, Wiesmuller KH, Junt T, Kienle S, Jung G, Walden P. Determination of T cell epitopes with random peptide libraries. J Immunol Methods 1996; 192: 149-155.
31. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997; 185: 1651-1659.
32. Hiemstra HS, van Veelen PA, Geluk A, Schloot NC, de Vries RRP, Ottenhoff THM et al. Limitations of homology searching for identification of T-cell antigens with library derived mimicry epitopes. Vaccine 1999; 18: 204-208.
33. Nemoto Y, Arribas M, Haffner C, DeCamilli P. Synaptojanin 2, a novel synaptojanin isoform with a distinct targeting domain and expression pattern. J Biol Chem 1997; 272: 30817-30821.
34. Sakisaka T, Itoh T, Miura K, Takenawa T. Phosphatidylinositol 4,5-bisphosphate phosphatase regulates the rearrangement of actin filaments. Mol Cell Biol 1997; 17: 3841-3849.
35. Takenawa T, Itoh T, Fukami K. Regulation of phosphatidylinositol 4,5-bisphosphate levels and its roles in cytoskeletal re-organization and malignant transformation. Chem Phys Lipids 1999; 98: 13-22.
36. Guo S, Stolz LE, Lemrow SM, York JD. SAC1-like domains for yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. J Biol Chem 1999; 274: 12990-12995.
37. McPherson PS, Garcia EP, Slepnev VI, David C, Zhang X, Grabs D et al. A presynaptic inositol-5-phosphatase. Nature 1996; 379: 353-357.
38. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996; 274: 2086-2089.
39. So CW, So CK, Cheung N, Chew SL, Sham MH, Chan LC. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis. Leukemia 2000; 14: 594-601.
40. Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F et al. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). Blood 1998; 92: 1125-1130.
41. Ramjaun AR, McPherson PS. Tissue-specific alternative splicing generates two synaptojanin isoforms with differential membrane binding properties. J Biol Chem 1996; 271: 24856-24861.
42. Khvotchev M, Sudhof TC. Developmentally regulated alternative splicing in a novel synaptojanin. J Biol Chem 1998; 273: 2306-2311.